NDC announces voluntary recall of HydroFinity Hydrophilic Guidewires

NewsGuard 100/100 Score

Nitinol Devices & Components, Inc. (NDC) announced today a voluntary recall of its HydroFinity™ Hydrophilic Guidewires. The HydroFinity Guidewire is a product developed and manufactured by NDC and distributed by Covidien. It is a nitinol-core, polymer-jacketed guidewire with a hydrophilic coating intended for use in catheter placement and other procedures to treat vascular diseases.

NDC is conducting this recall due to two reports of the outer polymer jacket to the core wire being damaged when the guidewire was withdrawn rapidly through certain delivery catheters and ten cases where the product was less severely damaged during use. Damage to the jacket can result in embolization of polymer, potentially leading to vessel occlusion or damage. Vessel occlusion may necessitate surgical intervention to resolve. Two cases were reported where the polymer jacket separated from the device and embolized. One case required surgical intervention.

NDC and Covidien have taken the necessary steps to prevent future shipments of the recalled products. Covidien alerted customers by letter on June 3, 2014 and is recalling all product. Unused product should be returned to Covidien. Additionally, NDC has notified regulatory agencies in the countries where the HydroFinity Guidewire is distributed: U.S., Belgium, Denmark, France, Germany, Italy, Norway, Sweden, UK and Canada.

NDC has apprised the U.S. Food and Drug Administration (FDA) of this action. Any adverse events experienced with the use of this product and/or quality problems should be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring the benefits of blueberries: Studies link extract to reduced cognitive aging